FDA again rejects Atara, Pierre Fabre’s cell therapy for Epstein-Barr virus
Article Title: FDA again rejects Atara, Pierre Fabre’s cell therapy for Epstein-Barr virus Publication Date: January 12, 2026 The FDA has recently rejected, for the second time, a T cell therapy for a grave transplant complication related to Epstein-Barr virus,…